Literature DB >> 22935395

Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.

Matthew H Stenmark1, Xu-Wei Cai, Kerby Shedden, James A Hayman, Shuanghu Yuan, Timothy Ritter, Randall K Ten Haken, Theodore S Lawrence, Feng-Ming Spring Kong.   

Abstract

PURPOSE: To investigate the plasma dynamics of 5 proinflammatory/fibrogenic cytokines, including interleukin-1beta (IL-1β), IL-6, IL-8, tumor necrosis factor alpha (TNF-α), and transforming growth factor beta1 (TGF-β1) to ascertain their value in predicting radiation-induced lung toxicity (RILT), both individually and in combination with physical dosimetric parameters. METHODS AND MATERIALS: Treatments of patients receiving definitive conventionally fractionated radiation therapy (RT) on clinical trial for inoperable stages I-III lung cancer were prospectively evaluated. Circulating cytokine levels were measured prior to and at weeks 2 and 4 during RT. The primary endpoint was symptomatic RILT, defined as grade 2 and higher radiation pneumonitis or symptomatic pulmonary fibrosis. Minimum follow-up was 18 months.
RESULTS: Of 58 eligible patients, 10 (17.2%) patients developed RILT. Lower pretreatment IL-8 levels were significantly correlated with development of RILT, while radiation-induced elevations of TGF-ß1 were weakly correlated with RILT. Significant correlations were not found for any of the remaining 3 cytokines or for any clinical or dosimetric parameters. Using receiver operator characteristic curves for predictive risk assessment modeling, we found both individual cytokines and dosimetric parameters were poor independent predictors of RILT. However, combining IL-8, TGF-ß1, and mean lung dose into a single model yielded an improved predictive ability (P<.001) compared to either variable alone.
CONCLUSIONS: Combining inflammatory cytokines with physical dosimetric factors may provide a more accurate model for RILT prediction. Future study with a larger number of cases and events is needed to validate such findings.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22935395      PMCID: PMC3646089          DOI: 10.1016/j.ijrobp.2012.03.067

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Cytokine profiling for prediction of symptomatic radiation-induced lung injury.

Authors:  Justin P Hart; Gloria Broadwater; Zahid Rabbani; Benjamin J Moeller; Robert Clough; Dale Huang; Gregory A Sempowski; Mark Dewhirst; Salvatore V Pizzo; Zeljko Vujaskovic; Mitchell S Anscher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-22       Impact factor: 7.038

Review 2.  Using biological markers to predict risk of radiation injury.

Authors:  Katharina Fleckenstein; Benjamin Gauter-Fleckenstein; Isabel L Jackson; Zahid Rabbani; Mitchell Anscher; Zeljko Vujaskovic
Journal:  Semin Radiat Oncol       Date:  2007-04       Impact factor: 5.934

3.  Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Authors:  Feng-Ming Kong; James A Hayman; Kent A Griffith; Gregory P Kalemkerian; Douglas Arenberg; Susan Lyons; Andrew Turrisi; Allen Lichter; Benedick Fraass; Avraham Eisbruch; Theodore S Lawrence; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-02       Impact factor: 7.038

Review 4.  Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis.

Authors:  Feng-Ming Kong; Randall Ten Haken; Avraham Eisbruch; Theodore S Lawrence
Journal:  Semin Oncol       Date:  2005-04       Impact factor: 4.929

5.  High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.

Authors:  Feng-Ming Kong; Randall K Ten Haken; Matthew J Schipper; Molly A Sullivan; Ming Chen; Carlos Lopez; Gregory P Kalemkerian; James A Hayman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

6.  Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.

Authors:  Dominique Arpin; David Perol; Jean-Yves Blay; Lionel Falchero; Line Claude; Sylvie Vuillermoz-Blas; Isabelle Martel-Lafay; Chantal Ginestet; Laurent Alberti; Dimitri Nosov; Bénédicte Etienne-Mastroianni; Vincent Cottin; Maurice Perol; Jean-Claude Guerin; Jean-François Cordier; Christian Carrie
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

7.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Authors:  M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

8.  Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.

Authors:  Katrien De Jaeger; Yvette Seppenwoolde; Harm H Kampinga; Liesbeth J Boersma; José S A Belderbos; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

9.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8.

Authors:  W S Simonet; T M Hughes; H Q Nguyen; L D Trebasky; D M Danilenko; E S Medlock
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Cytokine plasma levels: reliable predictors for radiation pneumonitis?

Authors:  Claudia E Rübe; Jan Palm; Michael Erren; Jochen Fleckenstein; Jochem König; Klaus Remberger; Christian Rübe
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  41 in total

1.  Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.

Authors:  Sawsan Rashdan; John D Minna; David E Gerber
Journal:  Lancet Respir Med       Date:  2018-06       Impact factor: 30.700

2.  A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy.

Authors:  Yi Luo; Daniel L McShan; Martha M Matuszak; Dipankar Ray; Theodore S Lawrence; Shruti Jolly; Feng-Ming Kong; Randall K Ten Haken; Issam El Naqa
Journal:  Med Phys       Date:  2018-06-04       Impact factor: 4.071

3.  Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship.

Authors:  Peter G Hawkins; Philip S Boonstra; Stephen T Hobson; Jason W D Hearn; James A Hayman; Randall K Ten Haken; Martha M Matuszak; Paul Stanton; Gregory P Kalemkerian; Nithya Ramnath; Theodore S Lawrence; Matthew J Schipper; Feng-Ming Spring Kong; Shruti Jolly
Journal:  Radiother Oncol       Date:  2017-09-23       Impact factor: 6.280

4.  Development of a Fully Cross-Validated Bayesian Network Approach for Local Control Prediction in Lung Cancer.

Authors:  Yi Luo; Daniel McShan; Dipankar Ray; Martha Matuszak; Shruti Jolly; Theodore Lawrence; Feng Ming Kong; Randall Ten Haken; Issam El Naqa
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-05-02

5.  Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?

Authors:  Jian-Yue Jin; Anxin Gu; Weili Wang; Nancy L Oleinick; Mitchell Machtay; Feng-Ming Spring Kong
Journal:  Radiother Oncol       Date:  2020-05-06       Impact factor: 6.280

Review 6.  Molecular mechanisms and treatment of radiation-induced lung fibrosis.

Authors:  Nian-Hua Ding; Jian Jian Li; Lun-Quan Sun
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

7.  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.

Authors:  Paul Zarogoulidis; Lonny Yarmus; Kaid Darwiche; Robert Walter; Haidong Huang; Zhigang Li; Bojan Zaric; Kosmas Tsakiridis; Konstantinos Zarogoulidis
Journal:  Immunome Res       Date:  2013-08-12

8.  Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.

Authors:  Shulian Wang; Jeff Campbell; Matthew H Stenmark; Jing Zhao; Paul Stanton; Martha M Matuszak; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-14       Impact factor: 7.038

Review 9.  Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.

Authors:  Dirk De Ruysscher; Jianyue Jin; Tim Lautenschlaeger; Jin-Xiong She; Zhongxing Liao; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 10.  Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?

Authors:  Carsten Herskind; Christopher J Talbot; Sarah L Kerns; Marlon R Veldwijk; Barry S Rosenstein; Catharine M L West
Journal:  Cancer Lett       Date:  2016-03-02       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.